News

International humanitarian project,International Human Rights Commission (IHRC)

in collaboration with the Omnimedica AG


Sir. Rafal Marcin Wasik (Source: AK )
IHRC
(Source: AK)
USPA NEWS - Omnimedica AG, is a spin-off company of the world leading Swiss Federal Institute of Technology  “ETH Zurich“. Omnimedica develops alternatives to traditional chemical pharmaceuticals that offer significantly better tolerability and fewer side effects. For example, a cortisone substitute for inflammatory skin diseases such as atopic dermatitis, psoriasis or atopic eczema has recently been developed, which does not require cortisone.
As part of an international humanitarian project, Omnimedica AG, in collaboration with the International Human Rights Commission (IHRC), wants to provide the latest developments to a number of children who have no opportunity to access these products and to treat their illness.
AG Dr Hans E. Holzgang and Director Olena Reutter,
Source: AK
IHRC
Source: AK
Aurangzeb Akbar
Source: AK
AG Dr Hans E. Holzgang and Director Olena Reutter,
Source: AK
International humanitarian project,International Human Rights Commission (IHRC) , in collaboration with the Omnimedica AG Omnimedica AG, is a spin-off company of the world leading Swiss Federal Institute of Technology  “ETH Zurich“. Omnimedica develops alternatives to traditional chemical pharmaceuticals that offer significantly better tolerability and fewer side effects. For example, a cortisone substitute for inflammatory skin diseases such as atopic dermatitis, psoriasis or atopic eczema has recently been developed, which does not require cortisone. As part of an international humanitarian project, Omnimedica AG, in collaboration with the International Human Rights Commission (IHRC), wants to provide the latest developments to a number of children who have no opportunity to access these products and to treat their illness the owner of Omnimedica AG Dr Hans E. Holzgang and Director Olena Reutter, Daniel Blaszczyk. Zurich,Switzerland. ............................. ....... AURANGZEB AKBAR .........
Liability for this article lies with the author, who also holds the copyright. Editorial content from USPA may be quoted on other websites as long as the quote comprises no more than 5% of the entire text, is marked as such and the source is named (via hyperlink).